Ventricular tachycardia


Published on

Published in: Health & Medicine
No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Ventricular tachycardia

  1. 1. VENTRICULAR TACHYCARDIA Dr. Y. Sridhar M.D. Consultant Intensivist Dept. of Critical Care Medicine Apollo Health City, Hyderabad
  2. 2. Definition• Wide complex rhythm QRS>0.12s• Rate > 100 (or120) bpm• Origin: from one of the Ventricles i.e., distal to the bundle of His.• Three or more consecutive beats on a ECG.
  3. 3. Classification• Duration of Episodes• Morphology• Symptoms
  4. 4. 1.Duration of Episodes• Three or More beats on an ECG at a rate >100bpm originating from Ventricles• Non Sustained VT : If rhythm self-terminates spontaneously in less than 30seconds• Sustained VT : If rhythm lasts > 30seconds (Even if it self-terminates spontaneously after 30s)
  5. 5. 2.Morphology• Monomorphic VT : same configuration beat to beat.• Polymorphic VT : Continually changing QRS morphology• Sinusoidal VT :sinusoidal appearance of rhythm• Accelerated idioventricular rhythm (AIVR)
  6. 6. Monomorphic VT• Most common cause : circuit through a region of old MI.• Idiopathic VT (less common) No identifiable cause.• Right Ventricular outflow tract (RVOT) tachycardia: MC Idiopathic VT LBBB Morphology with inferior axis.
  7. 7. Polymorphic VTCauses• Active cardiac Ischemia• Electrolyte Disturbances• Drug Toxicity• FamilialTorsade de pointes (twisting of points)• Waxing and waning QRS amplitude during tachycardia associated with prolonged QT interval
  8. 8. • Sinusoidal VT: seen in severe electrolyte disturbances • Hyperkalemia • Hypocalcemia • Hypomagnesemia• AIVR » Wide complex ventricular rhythm at a rate of 40-120bpm » Usually hemodynamically stable » MC cause :reperfusion arrhytmia in first 12hrs after acute MI or during periods of elevated sympathetic tone. » Typically preceded by sinus slowing » No treatment necessary. Self terminates.
  9. 9. Pathophysiology• Monomorphic VT : • Increased automaticity of a single point in either left or right ventricle • Reentry circuit within the ventricle• Polymorphic VT : • Abnormalities in ventricular muscle repolarization
  10. 10. Etiology• Structural Heart Disease : MI, Cardiomyopathies (HCM), Myocarditis• Electrolyte Abnormalities : Hypokalemia, Hyperkalemia, Hypocalcemia, Hypomagnesemia• Sympathomimetic agents : Ionotropes.• Drug toxicity : Digitalis, Methamphetamine, Cocaine• Systemic diseases : Sarcoidosis, RA, SLE.• Structural Congenital Disorders : Right ventricular dysplasia, TOF
  11. 11. EtiologyProlonged QT Interval• Acquired : • K Channel blocking medication : Quinidine, Erythromycin, Clarithromycin,Haloperidol, Droperidol • Type 1A antiarrythmics : sotalol, amiodarone,• Congenital : • Brugada syndrome • Congenital long and short QT syndromes • Catecholamingeric polymorphic VT
  12. 12. Diagnosis• “All WCT is VT until proven otherwise”• AV dissociaton : Dissociation of P wave from QRS complex.• QRS Concordance : Absence of rS or Rs complex in any precordial lead• RS > 100ms• Capture beats : Supraventricular beat conducts to ventricle depolarising ahead of the next tachycardia beat• Fusion beats : Depolarisation simultanously with excitation from a ventricular focus.
  14. 14. Ultra simple Brugada Criteria• In 2010 Joseph Brugada published simplified criteria• Measuring R wave peak time (RWPT) in Lead Ⅱ• RWPT > 50ms• It measures duration of onset of QRS to first change in polarity
  15. 15. Differential Diagnosis• SVT with aberrant intraventricular conduction• Preexcited Tachycardia (associated with or mediated by accessory pathway)• BBB• Ventricular paced rhythms
  16. 16. Symptoms• Chest Pain• Light headedness• Palpitations• Syncope• Sudden Cardiac Death (SCD) : • Ambulatory ECG records at SCD have shown 50- 60% at sustained monomorphic VT as the initial event.
  17. 17. TreatmentDepends on Hemodynamics• Unstable VT• Stable VT
  18. 18. ACLS Cardiac Arrest Algorithm. Neumar R W et al. Circulation 2010;122:S729-S767Copyright © American Heart Association
  19. 19. Stable VT• Anti arrhythmic drug (AAD) therapy• Implantable Cardioverter-Defibrillator (ICD)• Catheter Ablation Therapy (CAT)• Antiarrhythmic surgery
  20. 20. Tachycardia Algorithm. Neumar R W et al. Circulation 2010;122:S729-S767Copyright © American Heart Association
  21. 21. AMIODARONE• Large volume of distribution & long half life• Contraindications • Iodine sensitivity • Sinus bradycardia • Heart block• Precautions • Incompatible with NS • Preferable via CVC• Adverse effects – Short term : Skin reactions,Brady, hypotension, corneal microdeposits.
  22. 22. AMIODARONE – Long term : • Pulmonary fibrosis, alveolitis, pneumonitis • Liver dysfunction..monitor LFT • Hypo or Hyperthyroidism (check TFT before starting) • Peripheral neuropathy, myopathy, Cerebellar dysfunction.• Concomitant Beta and Calcium channel Blockers: Increased risk of bradycardia, AV Block• Potentiates effect of Digoxin, Theophylline and Warfarin– Reduce dose
  23. 23. Implantable cardioverter- defibrillator (ICD)• ICD therapy compared with conventional AAD associated with mortality reduction of 23-55% depending on risk group.• Current ICD options: – Single chamber – Dual chamber – Biventricular cardiac resynchronization – Multilevel shock discharge for VT or VFComplications: Inappropriate shock discharge Defibrillator storm Infections Exacerbation of HF
  24. 24. External Defibrillator• Automated external Defibrillator• Wearable automatic defibrillator – Worn under the clothing – Delivers shock whenever VF is detected.
  25. 25. • Procedure targets origin of VT• Useful in recurrent VT or “VT storm”.• Catheter is placed into heart chambers through femoral vein• Radiofrequency energy is applied which produces a small burn of about 4 to 5mm in diameter• Currently recommended in early treatment of VT when AAD are not preferred or tolerated.
  26. 26. Figure 2. Mapping of VT. A 3-dimensional real-time map of the ventricle (created during the procedure) merged with a computed tomography scan (obtained before the procedure). Tung R et al. Circulation 2010;122:e389-e391Copyright © American Heart Association
  27. 27. Recurrent VT : Long term Management• Risk of recurrence after successful resuscitation : 30-40%• Management of Intercurrent diseases• Implantable Cardioverter Defibrillator• Long term therapy on Amiodarone.
  28. 28. Antiarrhythmic surgery• Surgical resection of arrhythmogenic focus• Cardiac Sympathectomy• Aneurysm resection
  29. 29. Thank you!